An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT06655519 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma
Plasma Cell Leukemia

Interventions

BIOLOGICAL: CAR-T（RD140 injection）

Sponsor

Peking University People's Hospital